Group Education for Cancer Screening
Trial Summary
What is the purpose of this trial?
To determine the feasibility of a group-based education intervention to improve adherence to recommend surveillance and risk reducing procedures, with a focus at medically underserved women and racial/ethnic minorities with BRCA 1 and 2.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, certain chemotherapeutic or anti-leukemic agents are not allowed during the study, except for specific cases like intrathecal therapy or limited doses of cytarabine and hydroxyurea. It's best to discuss your current medications with the study team.
What data supports the effectiveness of the treatment Education Content in the clinical trial Group Education for Cancer Screening?
Group educational sessions have been shown to be effective in helping cancer patients understand their condition and treatment options. For example, a study at the University of California San Francisco found that breast cancer survivors who attended group educational sessions were more likely to use follow-up care and found the information clear and helpful.12345
Is group education for cancer screening safe for humans?
How does group education for cancer screening differ from other treatments?
Group education for cancer screening is unique because it focuses on educating patients in a group setting, which has been shown to increase knowledge and awareness about cancer screening more effectively than individual education. This approach leverages group dynamics to enhance learning and motivation, making it a novel method compared to traditional one-on-one educational sessions.1112131415
Research Team
Jose Rauh-Hain, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for medically underserved women and racial/ethnic minorities who have BRCA 1 or 2 gene mutations, which are linked to a higher risk of cancer. Participants should be interested in learning about surveillance and procedures to reduce their cancer risk.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive group-based education to improve adherence to surveillance and risk-reducing procedures
Follow-up
Participants are monitored for safety and effectiveness after the intervention, including completion of follow-up surveys
Treatment Details
Interventions
- Education Content
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor